Dr AUGER Cyril

Fiche personne


coordonnées

Centre de Recherche en Biomédecine de Strasbourg
1 rue Eugène Boeckel
67084 STRASBOURG Cedex

cyril.auger@unistra.fr

Territoire

Alsace

Statut

Chercheur

Publications


Potential of dapagliflozin to prevent vascular remodeling in the rat carotid artery following balloon injury.

Matsushita K, Sato C, Bruckert C, Gong D, Amissi S, Hmadeh S, Fakih W, Remila L, Lessinger JM, Auger C, Jesel L, Ohlmann P, Kauffenstein G, Schini-Kerth VB, Morel O

Atherosclerosis. 2024 05 23;:117595

COVID-19 promotes endothelial dysfunction and thrombogenicity: Role of pro-inflammatory cytokines/SGLT2 pro-oxidant pathway.

Mroueh A, Fakih W, Carmona A, Trimaille A, Matsushita K, Marchandot B, Qureshi AW, Gong DS, Auger C, Sattler L, Reydel A, Hess S, Oulehri W, Vollmer O, Lessinger JM, Meyer N, Pieper MP, Jesel L, Bäck M, Schini-Kerth V, Morel O

J Thromb Haemost. 2023 10 3;:

Empagliflozin prevents angiotensin II-induced hypertension related micro and macrovascular endothelial cell activation and diastolic dysfunction in rats despite persistent hypertension: Role of endothelial SGLT1 and 2.

Bruckert C, Matsushita K, Mroueh A, Amissi S, Auger C, Houngue U, Remila L, Chaker AB, Park SH, Algara-Suarez P, Belcastro E, Jesel L, Ohlmann P, Morel O, Schini-Kerth VB

Vascul Pharmacol. 2022 08 6;:107095

Voir plus